Medication-info.com Search Menu

Etravirine (Intelence): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Being discontinued since April 28, 2026
Strength:
100 mg, 200 mg
Brand names:
Active ingredient:

Patient information: uses, side effects, how to take - Etravirine

What is Etravirine?

Etravirine is a prescription medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection in combination with other HIV-1 medicines, in adults and children 2 years of age and older who have taken HIV-1 medicines in the past.

HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

Etravirine is not recommended for use in children less than 2 years of age.

What should I tell my healthcare provider before taking Etravirine?

Before taking Etravirine tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems, including hepatitis B or C.
  • are pregnant or plan to become pregnant. Tell your healthcare provider if you become pregnant during treatment with Etravirine.

    Pregnancy Registry:There is a pregnancy registry for people who take Etravirine during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.

  • are breastfeeding or plan to breastfeed. Do not breastfeed if you take Etravirine.

    • You should not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.
    • Etravirine can pass to your baby in your breast milk.
    • Talk with your healthcare provider about the best way to feed your baby.

Tell your healthcare provider about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Some medicines may interact with Etravirine. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

  • You can ask your healthcare provider or pharmacist for a list of medicines that interact with Etravirine.
  • Do not start a new medicine without telling your healthcare provider.Your healthcare provider can tell you if it is safe to take Etravirine with other medicines.

How should I take Etravirine?

  • Stay under the care of your healthcare provider during treatment with Etravirine.
  • Take Etravirine tablets every day exactly as prescribed by your healthcare provider.
  • Your healthcare provider will tell you how many Etravirine tablets to take and when to take them. Talk to your healthcare provider if you have questions about when to take Etravirine.
  • Take Etravirine 2 times each day.
  • If your child takes Etravirine, your healthcare provider will prescribe the right dose based on your child's weight.
  • Always take Etravirine following a meal.Do not take Etravirine on an empty stomach. Etravirine may not work as well if you take it on an empty stomach.

  • Do not change your dose or stop taking Etravirine without first talking with your healthcare provider.
  • Swallow Etravirine tablets whole, with liquid, such as water. Do not chew the tablet(s).
  • If you are unable to swallow Etravirine tablets whole, you may take your dose of Etravirine as follows:

    Step 1: Measure approximately 5 mL (1 teaspoon) of water and pour into a cup.

    Step 2: Place the tablets in the cup containing 5 mL of water. If needed, add more water to cover the tablets. Do not put the tablets in other liquids.

    Step 3: Stir well until the water looks milky.

    Step 4: Add a small amount (approximately 15 mL or 1 tablespoon) of liquid. Water may be used but adding orange juice or milk rather than water may make it easier to take. Do not use warm (temperature more than 104°F or 40°C) or carbonated beverages.

    Step 5: Drink the mixture right away.

    Step 6: Add more orange juice, milk, or water to the cup to rinse the cup several times and completely swallow each time to make sure you take your entire dose of Etravirine.

  • It is important that you do not miss or skip doses of Etravirine during treatment.
  • When your supply of Etravirine starts to run low, get more from your healthcare provider or pharmacy. It is important not to run out of Etravirine. The amount of HIV in your blood may increase if the medicine is stopped even for a short time.
  • If you take too much Etravirine, call your healthcare provider or go to the nearest emergency room right away.

What are the possible side effects of Etravirine?

Etravirine can cause serious side effects including:

  • Severe skin rash and allergic reactions.Skin rash is a common side effect of Etravirine. The risk of getting a skin rash is higher in females. Rarely, rash can be severe and may lead to death. Severe skin rash with blisters or peeling skin, including the area around the mouth or eyes, may happen more frequently in children less than 18 years of age who take Etravirine in combination with other HIV-1 medicines than in adults. Call your healthcare provider right away if a rash develops; severe cases may need to be treated in a hospital.

If you get a rash with any of the following symptoms, stop taking Etravirine and call your healthcare provider or get medical help right away:

  • fever
  • generally ill feeling
  • extreme tiredness
  • muscle or joint aches
  • blisters or sores in mouth
  • blisters or peeling of the skin
  • redness or swelling of the eyes
  • swelling of the mouth, lips, or face
  • problems breathing

Sometimes allergic reactions can affect body organs, such as your liver. Call your healthcare provider right away if you have any of the following signs or symptoms of liver problems:

  • yellowing of your skin or whites of your eyes
  • dark or tea colored urine
  • pale colored stools (bowel movements)
  • nausea or vomiting
  • loss of appetite
  • pain, aching, or tenderness on the right side of your stomach area
  • Changes in your immune system (Immune Reconstitution Syndrome)can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Call your healthcare provider right away if you start having any new symptoms after starting your HIV-1 medicines.
  • Changes in body fatcan happen in people taking HIV-1 medicines. These changes may include an increased amount of fat in the upper back and neck ("buffalo hump"), breast, and around the middle of your body (trunk). Loss of fat from the legs, arms, and face may also happen. The exact cause and long-term health effects of these problems are not known.

The most common side effects of Etravirine in adults include rash as well as numbness, tingling or pain in the hands or feet.

The most common side effects of Etravirine in children include rash and diarrhea.

These are not all the possible side effects of Etravirine.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Etravirine?

  • Store Etravirine tablets at room temperature between 68°F to 77°F (20°C to 25°C).
  • Keep Etravirine in the original bottle.
  • Keep the bottle tightly closed to protect Etravirine from moisture.
  • The Etravirine bottle contains a desiccant packet to help keep your medicine dry (protect it from moisture). The bottles of 100 mg and 200 mg tablets contain 3 desiccant packets. Keep the desiccant packets in the bottle. Do not eat the desiccant packets.

Keep Etravirine and all medicines out of the reach of children.

General information about the safe and effective use of Etravirine

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Etravirine for a condition for which it was not prescribed. Do not give Etravirine to other people, even if they have the same symptoms that you have. It may harm them. You can ask your healthcare provider or pharmacist for information about Etravirine that is written for health professionals.

What are the ingredients in Etravirine?

Active ingredient:etravirine.

100 mg Etravirine tablets contain the following inactive ingredients:colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.

200 mg Etravirine tablets contain the following inactive ingredients:colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, and silicified microcrystalline cellulose.

Manufactured for:

Patriot Pharmaceuticals, LLC, Horsham, PA 19044, USA

For patent information: www.janssenpatents.com

For more information, call Patriot Pharmaceuticals, LLC at 1-800-667-8570.

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 022187 · View the label on DailyMed

Revision date stated in the text: April 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Etravirine

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredient Etravirine
Dosage form Tablet
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) JANSSEN R AND D
FDA approval NDA 022187New Drug Application (NDA) Approved January 18, 2008
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Therapeutic equivalence (TE) code ABCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Generics Intelence with the same TE code
Manufacturers 6 labelers list this drug on DailyMed
Drug shortage
  • Being discontinued since April 28, 2026
Packages (NDC)
Package
100 mg – 120 in 1 bottle, plastic NDC 10147-0570-1
200 mg – 60 in 1 bottle, plastic NDC 10147-0571-1

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.